GSK Eyes AnaptysBio (ANAB) Acquisition to Secure Drug Control

finance.yahoo.com · 2026-08-17

Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here. The fund achieved an approximate 11% net return in the second quarter, indicating progress from the first quarter. Key changes to the portfolio will include lower concentration and increased investments with near-term catalysts, […]

Read the full story at finance.yahoo.com →